> ## Content Index
> Fetch the complete content index at: https://www.whiteroseintelligence.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Novavax
- URL: https://www.whiteroseintelligence.com/novavax-is-an-american-biotechnology-company-based-in-gaithersburg-maryland-history-novavax-sponsored-the-options-ix-for-the-control-of-influenza-conference-from-august-24-28-2016-in-ch/
- Published: 1999-01-02T21:19:00.000Z
- Updated: 2025-01-03T20:37:35.000Z
- Author: Liam Sturgess
- Tags: Profiles, #docs, #organization

**Novavax** is an American biotechnology company based in Gaithersburg, Maryland.

## History

Novavax sponsored the OPTIONS IX for the Control of Influenza conference from August 24-28, 2016 in Chicago, Illinois.[\[1\]](#fn1)

### COVID-19

On April 13, 2020, the [World Health Organization](https://www.whiteroseintelligence.com/World-Health-Organization) (WHO) published a "Public statement for collaboration on COVID-19 vaccine development." Gale Smith, Novavax's Chief Scientist, was a signatory.[\[2\]](#fn2)

Novavax is a participating organization in the [Accelerating COVID-19 Therapeutic Interventions and Vaccines](https://www.whiteroseintelligence.com/Accelerating-COVID-19-Therapeutic-Interventions-and-Vaccines) initiative, first announced April 17, 2020.[\[3\]](#fn3)

Novavax received up to $399 million from the [Coalition for Epidemic Preparedness Innovations](https://www.whiteroseintelligence.com/Coalition-for-Epidemic-Preparedness-Innovations) (CEPI) for the development of its COVID-19 vaccine candidate.[\[4\]](#fn4)

Representatives of Novavax met with the [Government of Canada](https://www.whiteroseintelligence.com/Government-of-Canada)'s [COVID-19 Vaccine Task Force](https://www.whiteroseintelligence.com/COVID-19-Vaccine-Task-Force) on July 23 and December 10, 2020 to discuss its COVID-19 vaccine candidate.[\[5\]](#fn5)

On February 2, 2021, [Innovation, Science and Economic Development Canada](https://www.whiteroseintelligence.com/Innovation-Science-and-Economic-Development-Canada) signed a memorandum of understanding with Novavax to produce its COVID-19 vaccine candidate at [National Research Council Canada](https://www.whiteroseintelligence.com/National-Research-Council-Canada)'s Biologics Manufacturing Centre.[\[6\]](#fn6)

COVAX reached a supply agreement with Novavax for its Nuvaxovid product, as well as for Covovax, which the company co-developed with the Serum Institute of India (SII).[\[7\]](#fn7) Novavax CEO Stanley Erck attended the One World Protected event hosted by [Gavi, the Vaccine Alliance](https://www.whiteroseintelligence.com/Gavi-the-Vaccine-Alliance) on April 15, 2021, during which COVAX was officially launched.[\[8\]](#fn8)

On February 17, 2022, [Health Canada](https://www.whiteroseintelligence.com/Health-Canada) authorized the Novavax COVID-19 vaccine for use in adults.[\[9\]](#fn9)

Novavax sponsored the World Vaccine Congress Washington 2022, which took place from April 18-21, 2022.[\[10\]](#fn10)

On July 13, 2022, the [Food and Drug Administration](https://www.whiteroseintelligence.com/Food-and-Drug-Administration) granted an Emergency Use Authorization (EUA) for the Novavax COVID-19 vaccine.[\[11\]](#fn11)

## Organization

Novavax is a member or partner of:

- [Adult Vaccine Access Coalition](https://www.whiteroseintelligence.com/Adult-Vaccine-Access-Coalition) (AVAC)[\[12\]](#fn12)
- [Biotechnology Innovation Organization](https://www.whiteroseintelligence.com/Biotechnology-Innovation-Organization) (BIO)[\[13\]](#fn13)
- European Federation of Pharmaceutical Industries and Associations (EFPIA)[\[14\]](#fn14)
- [Medical CBRN Defense Consortium](https://www.whiteroseintelligence.com/Medical-CBRN-Defense-Consortium)[\[15\]](#fn15)
- National Foundation for Infectious Diseases (NFID)[\[16\]](#fn16)

Novavax has provided notable funding to:

- IDSA Foundation[\[17\]](#fn17)

### Personnel

| Name         | Position                                                                                     | Notes                                                                       |
| ------------ | -------------------------------------------------------------------------------------------- | --------------------------------------------------------------------------- |
| Stanley Erck | CEO[\[8:1\]](#fn8)                                                                           | \-                                                                          |
| Gale Smith   | Senior Vice President of Discovery and Pre-clinical Research, Chief Scientist[\[18\]](#fn18) | Protein Sciences                                                            |
| John Spears  | CEO (former)[\[19\]](#fn19)                                                                  | [Intradigm](https://www.whiteroseintelligence.com/Intradigm)[\[20\]](#fn20) |

## External links

- [Campfire Wiki](https://www.campfire.wiki/doku.php?id=pharmaceutical%5Fcompanies:novavax)
- [Website](https://www.novavax.com/)
- [Wikipedia](https://en.wikipedia.org/wiki/Novavax)

---

1. *OPTIONS IX Supporters.* OPTIONS IX. Retrieved July 7, 2017, from <https://web.archive.org/web/20170707010655/http://2016.isirv.org/options-ix-supporters> [↩︎](#fnref1)
2. Jasarevic, T. (2020, April 16). *Public statement for collaboration on COVID-19 vaccine development.* World Health Organization. <http://archive.today/2020.10.04-153106/https://www.who.int/news-room/detail/13-04-2020-public-statement-for-collaboration-on-covid-19-vaccine-development> [↩︎](#fnref2)
3. *ACTIV.* National Institutes of Health (NIH). Retrieved April 1, 2022, from <http://archive.today/2022.01.11-042823/https://www.nih.gov/research-training/medical-research-initiatives/activ> [↩︎](#fnref3)
4. *Our portfolio.* CEPI. Retrieved October 21, 2022, from <https://web.archive.org/web/20221021070613/https://cepi.net/research%5Fdev/our-portfolio/> [↩︎](#fnref4)
5. *COVID-19 Vaccine Task Force Registry of Interests.* (2023, March 27). Innovation, Science and Economic Development Canada. <http://archive.today/2023.07.09-180656/https://ised-isde.canada.ca/site/biomanufacturing/en/covid-19-vaccine-task-force/covid-19-vaccine-task-force-registry-interests> [↩︎](#fnref5)
6. *Backgrounder – Government of Canada investments in COVID-19 vaccines, therapeutics and biomanufacturing capacity.* (2021, February 2). Innovation, Science and Economic Development Canada. <http://archive.today/2021.02.17-210959/https://www.canada.ca/en/innovation-science-economic-development/news/2021/02/backgrounder--government-of-canada-investments-in-covid-19-vaccines-and-biomanufacturing-capacity.html> [↩︎](#fnref6)
7. *Gavi COVAX AMC 2021 Investment Opportunity Launch Event.* (2022, January 29). Gavi, the Vaccine Alliance. <https://web.archive.org/web/20220820112357/https://www.gavi.org/gavi-covax-amc-launch-event-april-2021> [↩︎](#fnref7)
8. *The Gavi COVAX AMC Investment Opportunity Launch Event Participant List.* (2021). Gavi, the Vaccine Alliance; USAID; U.S. Department of State. <https://web.archive.org/web/20220821050428/https://www.gavi.org/sites/default/files/covid/covax/Investment-Opportunity-Launch-Participant-List.pdf> [↩︎](#fnref8) [↩︎](#fnref8:1)
9. Parkhill, M. (2022, February 17). *Novavax vaccine authorized for use in Canada.* CTV News. <http://archive.today/2022.02.17-170358/https://www.ctvnews.ca/health/coronavirus/novavax-vaccine-authorized-for-use-in-canada-1.5785244> [↩︎](#fnref9)
10. *Sponsors & exhibitors | Vaccine Congress USA.* (2022, April 21). World Vaccine Congress Washington 2022\. <http://archive.today/2022.04.22-012231/https://www.terrapinn.com/conference/world-vaccine-congress-washington/sponsors-and-exhibitors.stm> [↩︎](#fnref10)
11. Capobianco, A. (2022, July 13). *Coronavirus (COVID-19) Update: FDA Authorizes Emergency Use of Novavax COVID-19 Vaccine, Adjuvanted.* Food and Drug Administration. <https://web.archive.org/web/20220713201410/https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-authorizes-emergency-use-novavax-covid-19-vaccine-adjuvanted> [↩︎](#fnref11)
12. *AVAC Member Organizations.* (2021). Adult Vaccine Access Coalition. <http://archive.today/2022.07.08-060340/https://adultvaccinesnow.org/our-membership/avac-member-organizations/> [↩︎](#fnref12)
13. *BIO Member Directory.* Biotechnology Innovation Organization. Retrieved September 30, 2022, from <https://web.archive.org/web/20220930103715/https://www.bio.org/bio-member-directory> [↩︎](#fnref13)
14. *Membership.* (2022). European Federation of Pharmaceutical Industries and Association. <https://web.archive.org/web/20220701031757/https://www.efpia.eu/about-us/membership/> [↩︎](#fnref14)
15. *Current Members.* MCDC. Retrieved January 3, 2023, from <http://archive.today/2023.01.03-195328/https://www.medcbrn.org/current-members/> [↩︎](#fnref15)
16. *Strategic Partners.* National Foundation for Infectious Diseases. Retrieved July 16, 2022, from <http://archive.today/2022.07.16-073224/https://www.nfid.org/about-nfid/strategic-partners/> [↩︎](#fnref16)
17. *Home.* IDSA Foundation. Retrieved October 8, 2022, from <https://web.archive.org/web/20221008025156/https://idsafoundation.org/> [↩︎](#fnref17)
18. *Meet Gale E. Smith, PhD.* Novavax. Retrieved April 17, 2023, from <https://web.archive.org/web/20230417112829/https://www.novavax.com/who-we-are/leadership/gale-e-smith-phd> [↩︎](#fnref18)
19. Ex-chief of Novavax hired as Intradigm CEO. (2002, November 28). *The Baltimore Sun,* C2\. <https://www.newspapers.com/image/248431447/?terms=Intradigm&match=1> [↩︎](#fnref19)
20. *Intradigm appoints John A. Spears Chairman and CEO.* (2002, December 2). PharmaBiz. <http://archive.today/2023.03.04-202058/http://test.pharmabiz.com/news/intradigm-appoints-john-a-spears-chairman-and-ceo-12922> [↩︎](#fnref20)